Erythropoietin combined with granulocyte colony-stimulating factor enhances MMP-2 expression in mesenchymal stem cells and promotes cell migration

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 31-36

  Yu, Qiang ^a,b   Chen, Long ^a   You, Yong ^b   Zou, Can ^a,b   Zhang, Youshun ^a   Liu, Qihuan ^a   Cheng, Fanjun ^a,b  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ERK1 2; Matrix metalloproteinase; Migration

Indexed keywords

ERYTHROPOIETIN; GELATINASE A; GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ADIPOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL MIGRATION; CELL MOTILITY; ENZYME ACTIVATION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; MALE; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 78651383672     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.387     Document Type: Article

References (22)

1. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999. (Pubitemid 29282067)
2. Zipori D: The stem state: plasticity is essential, whereas self-renewal and hierarchy are optional. Stem Cells 23: 719-726, 2005.
3. Mackenzie TC and Flake AW: Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27: 601-604, 2001.
4. Kawada H, Fujita J, Kinjo K, et al: Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104: 3581-3587, 2004. (Pubitemid 39564430)
5. Koc ON, Gerson SL, Cooper BW, et al: Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cance r patients receiving high-dose chemotherapy. J Clin Oncol 18: 307-316, 2000.
6. Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003.
7. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003. (Pubitemid 36542523)
8. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999. (Pubitemid 29220691)
9. Guccione M, Silbiger S, Lei J, et al: Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol 282: F164-F169, 2002. (Pubitemid 34654211)
10. Kuo L, Chang HC, Leu TH, et al: Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol 207: 729-734, 2006. (Pubitemid 43668237)
11. Heeschen C, Aicher A, Lehmann R, et al: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346, 2003. (Pubitemid 36988041)
12. Saito T, Usui N, Asai O, et al: Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF). J Infect Chemother 13: 426-428, 2007. (Pubitemid 350308156)
13. Carstanjen D, Ulbricht N, Iacone A, Regenfus M and Salama A: Matrix metalloproteinase-9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G-CSF Transfusion 42: 588-596, 2002.
14. Koh SH, Noh MY, Cho GW, Kim KS and Kim SH: Erythropoietin increases the motility of human bone marrow multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs. Stem Cells and Development 18: 411-421, 2009.
15. Tang J, Xie Q, Pan G, et al: Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur J Cardiothoracic Surg 3: 353-361, 2006. (Pubitemid 44051890)
16. Nakamura T, Shiojima S, Hirai Y, et al: Temporal gene expression changes during adipogenesis in human mesenchymal stem cells. Biochem Biophys Res Comm 303: 306-312, 2003. (Pubitemid 36338241)
17. Jaiswal N, Haynesworth SE, Caplan AI, et al: Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312, 1997. (Pubitemid 27065443)
18. Roufosse CA, Direkze NC, Otto WR and Wright NA: Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36: 585-597, 2004.
19. Zwezdaryk KJ, Coffelt SB, Figueroa YG, et al: Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Exp Hematol 35: 640-652, 2007.
20. Roufosse CA, Direkze NC, Otto WR and Wright NA: The effect of recombinant human erythropoietin on the migration of bone marrow derived mesenchymal stem cells in vitro. Chin J Hematol 29: 811-814, 2008.
21. De Becker A, van Hummelen P Bakkus M, Vande Broek I, De Wever J, De Waele M and van Riet I: Migration of culture-expanded humanmesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92: 440-449, 2007 (Pubitemid 350144289)
22. Ries C, Egea V, Karow M, Kolb H, Jochum M and Neth P: MMP-2, MT1-MMP and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109: 4055-4063, 2007.